16681-65-5, Name is 1-Methyl-1H-1,2,3-triazole, 16681-65-5, belongs to Triazoles compound, is considered to be a conventional heterocyclic compound, which is widely used in drug synthesis. The chemical synthesis route is as follows.
l-Methyl-5-tributylstannanyl-lH-[l,2,3]triazole; To a solution of 1 -methyl- lH-[l,2,3]triazole (1.33 g, 16 mmol) in THF (20 mL) at -78 0C, was added dropwise n-BuLi (11 mL,1.6M, 18 mmol). The mixture was stirred at -78 0C for 2 h before addition of Bu3SnCl (4.75 mL, 17.6 mmol). The mixture was stirred at this temperature for 1 h and at r.t. for 1 h. The mixture was concentrated in vacuo and hexanes was added. The insoluble material was removed by filtration and the filtrate was concentrated in vacuo to afford l-methyl-5-tributylstannanyl-lH- [l,2,33triazole (6.12 g, 82% yield) as a yellow syrup.
Statistics shows that 1-Methyl-1H-1,2,3-triazole is playing an increasingly important role. we look forward to future research findings about 16681-65-5.
Reference:
Patent; NOVARTIS AG; NOVARTIS PHARMA GMBH; WO2006/108591; (2006); A1;,
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics